Free Access
Med Sci (Paris)
Volume 28, Number 6-7, Juin–Juillet 2012
Page(s) 633 - 638
Section M/S Revues
Published online 16 July 2012
  1. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet 2012 ; 379 : 953–964. [CrossRef] [PubMed] [Google Scholar]
  2. Bach JF, Chalons S, Forier E, et al. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet 1996 ; 347 : 644–648. [CrossRef] [PubMed] [Google Scholar]
  3. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007 ; 357 : 470–476. [CrossRef] [PubMed] [Google Scholar]
  4. Guilherme L, Kalil J. Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J Clin Immunol 2010 ; 30 : 17–23. [CrossRef] [PubMed] [Google Scholar]
  5. Kaplan MH, Bolande R, Rakita L, Blair J. Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever. Association with cardiac failure. N Engl J Med 1964 ; 271 : 637–645. [CrossRef] [PubMed] [Google Scholar]
  6. Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 2001 ; 180 : 86–99. [CrossRef] [PubMed] [Google Scholar]
  7. Engel ME, Stander R, Vogel J, et al. Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies. PLoS One 2011 ; 6 : e25326. [CrossRef] [PubMed] [Google Scholar]
  8. Bryant PA, Robins-Browne R, Carapetis JR, Curtis N. Some of the people, some of the time: Susceptibility to acute rheumatic fever. Circulation 2009 ; 119 : 742–753. [CrossRef] [PubMed] [Google Scholar]
  9. Special writing group of the Committee on rheumatic rever, endocarditis, and Kawasaki disease of the Council on cardiovascular disease in the young of the American heart association. Guidelines for the diagnosis of rheumatic fever. Jones criteria, 1992 update. JAMA 1992 ; 268 : 2069–2073. [CrossRef] [PubMed] [Google Scholar]
  10. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005 ; 5 : 685–694. [CrossRef] [PubMed] [Google Scholar]
  11. WHO. Rheumatic fever and rheumatic heart disease. Report of a WHO expert Consultation. Geneva : WHO, 2001. [Google Scholar]
  12. McDonald M, Currie BJ, Carapetis JR. Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis 2004 ; 4 : 240–245. [CrossRef] [PubMed] [Google Scholar]
  13. Lennon D, Stewart J, Farrell E, et al. School-based prevention of acute rheumatic fever: a group randomized trial in New Zealand. Pediatr Infect Dis J 2009 ; 28 : 787–794. [CrossRef] [PubMed] [Google Scholar]
  14. Steer AC, Law I, Matatolu L, et al. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 2009 ; 9 : 611–616. [CrossRef] [PubMed] [Google Scholar]
  15. WHO. The WHO global programme for the prevention of rheumatic fever and rheumatic heart disease. WHO, 1999. [Google Scholar]
  16. Steer AC, Carapetis JR. Prevention and treatment of rheumatic heart disease in the developing world. Nat Rev Cardiol 2009 ; 6 : 689–698. [CrossRef] [PubMed] [Google Scholar]
  17. Council of Europe, Committee of Ministers. Recommendation n° R (94) 11 on screening as a tool of preventive medicine. 1994.–11.html. [Google Scholar]
  18. Marijon E, Celermajer DS, Tafflet M, et al. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation 2009 ; 120 : 663–668. [CrossRef] [PubMed] [Google Scholar]
  19. Mirabel M, Celermajer DS, Ferreira B, et al. Simplified echo-based approach for rheumatic heart disease screening. Eur Heart J Cardiovasc Imaging 2012 ; 25 mai (online). [Google Scholar]
  20. Carapetis JR, Hardy M, Fakakovikaetau T, et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat Clin Pract Cardiovasc Med 2008 ; 5 : 411–417. [CrossRef] [PubMed] [Google Scholar]
  21. Remenyi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease-an evidence-based guideline. Nat Rev Cardiol 2012 ; 9 : 297–309. [CrossRef] [PubMed] [Google Scholar]
  22. Webb R, Gentles T, Stirling J, Wilson N. Echocardiographic findings in NZ children from a low-risk population for acute rheumatic fever: implications for rheumatic heart disease screening. In : 62nd Annual scientific meeting of the Paediatric society of New Zealand. New Plymouth, NZ, 24th November 2010 (abstract). [Google Scholar]
  23. Marijon E, Ou P, Celermajer DS, et al. Echocardiographic screening for rheumatic heart disease. Bull World Health Org 2008 ; 86 : 84. [CrossRef] [Google Scholar]
  24. Marijon E, Celermajer DS, Jouven X. Management of patients with subclinical rheumatic heart disease. Int J Cardiol 2009 ; 134 : 295–296. [CrossRef] [PubMed] [Google Scholar]
  25. Celermajer DS, Chow C, Marijon E, et al. Cardiovascular diseases in the developing world. Prevalences, patterns and the potential of early detection. J Am Coll Cardiol 2012 (sous presse). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.